| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/02/2013 | WO2012163827A3 Ophthalmic preparation comprising a pgf2alpha analogue |
| 05/02/2013 | WO2012143576A3 Compounds for preventing, reducing and/or alleviating itchy skin condition(s) |
| 05/02/2013 | WO2012135868A8 Compositions and methods for the treatment and prevention of cardiac ischemic injury |
| 05/02/2013 | WO2012084126A3 Formulation of lacosamide |
| 05/02/2013 | WO2012061469A3 Crystalline forms of pralatrexate |
| 05/02/2013 | WO2012051116A8 Clevidipine emulsion formulations containing antimicrobial agents |
| 05/02/2013 | WO2012031515A3 Low-modification biocompatible high polymer sulfhydryl-modified derivatives, cross-linked material thereof, and uses of said material |
| 05/02/2013 | US20130109863 Hetero-substituted acetanilide derivatives as analgesic agents |
| 05/02/2013 | US20130109759 Formulations of quinones for the treatment of ophthalmic diseases |
| 05/02/2013 | US20130109755 Baclofen Formulations and Methods for Making Same |
| 05/02/2013 | US20130109754 Combination of an nsaid and an amino acid |
| 05/02/2013 | US20130109753 Sn-2-monoacylglycerols and lipid malabsorption |
| 05/02/2013 | US20130109752 DERIVATIVE OF 18beta-GLYCYRRHETINIC ACID APT TO SUPPRESS CANCER CELLS |
| 05/02/2013 | US20130109751 Lsd-1 enzyme inhibitors for inducing osteogenic differentiation |
| 05/02/2013 | US20130109750 Novel arylamide derivatives having antiandrogenic properties |
| 05/02/2013 | US20130109749 Micheliolide derivatives, medicinal composition, producing method and usage thereof |
| 05/02/2013 | US20130109748 Method for obtaining extract of calligonum species and extract thereof |
| 05/02/2013 | US20130109745 Anti-angiogenic composition containing macrolactin a and a derivative thereof as active ingredients |
| 05/02/2013 | US20130109741 MiRNA AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH MELANOMA, OR IN DISEASES OR CONDITIONS ASSOCIATED WITH ACTIVATED BRAF PATHWAY |
| 05/02/2013 | US20130109738 Control of Cardiac Growth, Differentiation and Hypertrophy |
| 05/02/2013 | US20130109736 Method for enhanced uptake of viral vectors in the myocardium |
| 05/02/2013 | US20130109733 Combination of Selected Analgesics and Cox-II Inhibitors |
| 05/02/2013 | US20130109730 Treatment of liver diseases in which iron plays a role in pathogenesis |
| 05/02/2013 | US20130109729 Pharmaceutical composition |
| 05/02/2013 | US20130109726 Sustained-release therapeutic agent for hypertension and renal dysfunction |
| 05/02/2013 | US20130109724 N-aminopyrrolylmethyltetrahydropyridines as anti-cancer agents |
| 05/02/2013 | US20130109722 Use of dabigatran etexilate for treating patients with pulmonary hypertension |
| 05/02/2013 | US20130109721 FAAH Inhibitors |
| 05/02/2013 | US20130109720 Indole inhibitors of crac |
| 05/02/2013 | US20130109719 Method of treating attention deficit disorders with d-threo methylphenidate |
| 05/02/2013 | US20130109718 1-cycloalkyl- or 1-heterocyclyl-hydroxyimino-3-phenyl-propanes |
| 05/02/2013 | US20130109717 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 05/02/2013 | US20130109716 N-aminotetrahydroisoquinolines as anti-cancer agents |
| 05/02/2013 | US20130109712 Statins for the Prevention or Treatment of Drug Addictions |
| 05/02/2013 | US20130109709 Methods of treating a bruton's tyrosine kinase disease or disorder |
| 05/02/2013 | US20130109708 Chemical Compounds |
| 05/02/2013 | US20130109707 Fluorouracil derivatives |
| 05/02/2013 | US20130109705 Combination |
| 05/02/2013 | US20130109703 Combination of a GPR119 Agonist and the DPP-IV Inhibitor Linagliptin for Use in the Treatment of Diabetes and Related Conditions |
| 05/02/2013 | US20130109702 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition |
| 05/02/2013 | US20130109701 Chemical Compounds |
| 05/02/2013 | US20130109699 Tetrahydrocarboline derivative |
| 05/02/2013 | US20130109698 Small Molecule Inhibitors of Functions of the HIV-1 Matrix Protein |
| 05/02/2013 | US20130109697 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof |
| 05/02/2013 | US20130109696 Chemical Compounds |
| 05/02/2013 | US20130109692 Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy |
| 05/02/2013 | US20130109691 Cosmetic Use of N-Heteroarybisamide Analogs and Related Compounds |
| 05/02/2013 | US20130109689 Novel Methods for Preparation of (+)-1-ethyl-4-[2-(4-morpholinyl)ethyl)-3,3-diphenyl-2-pyrrolidinone |
| 05/02/2013 | US20130109682 Cyclic ether compounds useful as kinase inhibitors |
| 05/02/2013 | US20130109680 Methods and compositions for ameliorating thiazide induced hyperlipidemia |
| 05/02/2013 | US20130109677 Multicyclic compounds and methods of use thereof |
| 05/02/2013 | US20130109676 Oxadiazole Diaryl Compounds |
| 05/02/2013 | US20130109675 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof |
| 05/02/2013 | US20130109674 Methods and compositions for treating and preventing trigeminal autonomic cephalgias, migraine, and vascular conditions |
| 05/02/2013 | US20130109671 Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases |
| 05/02/2013 | US20130109668 Azetidine compounds, compositions and methods of use |
| 05/02/2013 | US20130109665 Novel pyrazine derivatives |
| 05/02/2013 | US20130109664 Personal Care Compositions Comprising a Pyrithione and an Iron Chelator |
| 05/02/2013 | US20130109662 Fe(III) Complex Compounds For The Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anemias |
| 05/02/2013 | US20130109661 Imidazopyridazine compounds |
| 05/02/2013 | US20130109660 Novel pyrimidinecarboxamide derivatives |
| 05/02/2013 | US20130109657 C7-Fluoro Substituted Tetracycline Compounds |
| 05/02/2013 | US20130109655 Method for mitigating of Prostaglandin E2 reducing side effects of non-steroidal anti-inflammatory drugs |
| 05/02/2013 | US20130109654 Anti-cytomegalovirus activity of artemisinin-derived dimers |
| 05/02/2013 | US20130109651 Absorbable Implants And Methods Of Their Use In Hemostasis And In The Treatment Of Osseous Defects |
| 05/02/2013 | US20130109650 Composition containing oligosaccharides for the treatment/prevention of infections |
| 05/02/2013 | US20130109649 Fused bicyclic oxazolidinone cetp inhibitor |
| 05/02/2013 | US20130109648 Method for treating a human patient suffering from myeloid neoplasias using 5-aminoimidazole-4-carboxamide |
| 05/02/2013 | US20130109647 Methods and compositions for treating hepatitis c virus |
| 05/02/2013 | US20130109646 Method for treating glaucoma or ocular hypertension with an adenosine derivative |
| 05/02/2013 | US20130109645 Adenosine receptor agonists for the treatment and prevention of vascular or joint capsule calcification disorders |
| 05/02/2013 | US20130109644 Methods for treating cancers using oral formulations of cytidine analogs |
| 05/02/2013 | US20130109643 Metabolic inhibitor against tumors having an idh mutation |
| 05/02/2013 | US20130109642 Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies |
| 05/02/2013 | US20130109641 Use of flavonoide compounds for the prophylaxis and therapy of ischaemic or inflammatory heart and cardiovascular diseases |
| 05/02/2013 | US20130109640 Composition for treating or preventing neurodegenerative brain diseases comprising black bean extract |
| 05/02/2013 | US20130109639 Neprilysin inhibitors |
| 05/02/2013 | US20130109638 Anti-acne pharmaceutical composition |
| 05/02/2013 | US20130109628 Microrna compositions and methods related thereto |
| 05/02/2013 | US20130109620 Balaglitazone compositions and methods |
| 05/02/2013 | US20130109617 Substituted tetracycline compounds for treatment of bacillus anthracis infections |
| 05/02/2013 | US20130109615 Methods for inhibiting necrosis |
| 05/02/2013 | US20130109605 Composition and process for post-etch removal of photoresist and/or sacrificial anti-reflective material deposited on a substrate |
| 05/02/2013 | US20130109566 Pesticidal compositions and processes related thereto |
| 05/02/2013 | US20130108717 Compositions for the treatment of gynaecological disorders |
| 05/02/2013 | US20130108716 Jatropha Curcas Processing Method and Products |
| 05/02/2013 | US20130108713 Composition possessing antioxidant, immonomodulated, and antitumorous action and method of treating neoplasms |
| 05/02/2013 | US20130108710 Antimalarial Drug Which Contains 5-Aminolevulinic Acid or Derivative Thereof as Active Ingredient |
| 05/02/2013 | US20130108709 Treatment of mitochondria-related diseases and improvement of age-related metabolic deficits |
| 05/02/2013 | US20130108708 Dental composites comprising nanoparticles of amorphous calcium phosphate |
| 05/02/2013 | US20130108706 Dietary formulations |
| 05/02/2013 | US20130108696 Coated capsules and tablets of a fatty acid oil mixture |
| 05/02/2013 | US20130108694 Dry blend formulation of tetrahydrobiopterin |
| 05/02/2013 | US20130108691 Microrna as a cancer progression predictor and its use for treating cancer |
| 05/02/2013 | US20130108687 Compositions for use in treating or diagnosing bone disorders and/or cardiovascular disorders |
| 05/02/2013 | US20130108686 Method for the delivery of oligonucleotides |
| 05/02/2013 | US20130108680 Implantable tizanidine compositions and methods of treatment thereof |
| 05/02/2013 | US20130108675 Organic compounds |
| 05/02/2013 | US20130108673 Co-Therapy for Diabetic Conditions |
| 05/02/2013 | US20130108672 Pharmaceutical compositions for substituted quinazolinones |